Literature DB >> 18941867

Genetic characterization of adult infratentorial gliomas.

Tomoru Miwa1, Yuichi Hirose, Hikaru Sasaki, Eiji Ikeda, Kazunari Yoshida, Takeshi Kawase.   

Abstract

Adult infratentorial gliomas are rare and have not been well studied. We therefore conducted genetic analysis of those tumors to see if there was any characteristic that could be relevant in clinical management and understanding of tumorigenesis. Nineteen adult infratentorial gliomas were analyzed for chromosomal aberration by comparative genomic hybridization, and for expression of p53 and epidermal growth factor receptor (EGFR) by immunohistochemistry. The most frequent chromosomal aberration was the gain of 7p, and five of the seven cerebellar or fourth ventricle malignant gliomas had that aberration. However, the gain of 7q, the characteristic abnormality of supratentorial astrocytomas commonly associated with the gaining of 7p, was observed only in 1 of 11 adult infratentorial astrocytic tumors. Combined losses of 1p and 19q, the genetic hallmark of oligodendroglioma, were not observed. Results of immunohistochemistry of p53 and EGFR were comparable to those reported in supratentorial gliomas. Our findings might suggest the presence of distinct tumorigenic pathway in adult infratentorial gliomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941867     DOI: 10.1007/s11060-008-9714-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  11 in total

1.  PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.

Authors:  H Sasaki; M C Zlatescu; R A Betensky; Y Ino; J G Cairncross; D N Louis
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.

Authors:  Y Hirose; K Aldape; A Bollen; C D James; D Brat; K Lamborn; M Berger; B G Feuerstein
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms.

Authors:  M C Zlatescu; A TehraniYazdi; H Sasaki; J F Megyesi; R A Betensky; D N Louis; J G Cairncross
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

4.  Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.

Authors:  J Reifenberger; G U Ring; U Gies; L Cobbers; J Oberstrass; H X An; D Niederacher; W Wechsler; G Reifenberger
Journal:  J Neuropathol Exp Neurol       Date:  1996-07       Impact factor: 3.685

Review 5.  Chromosomal abnormalities subdivide neuroepithelial tumors into clinically relevant groups.

Authors:  Yuichi Hirose; Kazunari Yoshida
Journal:  Keio J Med       Date:  2006-06

6.  Alterations in p53, p21, and MIB-1 labeling index in primary human astrocytomas following radiation therapy.

Authors:  John W Henson; Wendy Hobbs; Arnab Chakravarti; David N Louis
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

7.  Grade II astrocytomas are subgrouped by chromosome aberrations.

Authors:  Yuichi Hirose; Kenneth D Aldape; Susan Chang; Kathleen Lamborn; Mitchel S Berger; Burt G Feuerstein
Journal:  Cancer Genet Cytogenet       Date:  2003-04-01

Review 8.  Malignant gliomas of the cerebellum: an analytic review.

Authors:  H R Djalilian; W A Hall
Journal:  J Neurooncol       Date:  1998-02       Impact factor: 4.130

9.  Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets.

Authors:  Wolf Mueller; Christian Hartmann; Annegret Hoffmann; Wolfgang Lanksch; Jürgen Kiwit; Jörg Tonn; Julian Veelken; Johannes Schramm; Michael Weller; Otmar D Wiestler; David N Louis; Andreas von Deimling
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

10.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

Authors:  J G Cairncross; K Ueki; M C Zlatescu; D K Lisle; D M Finkelstein; R R Hammond; J S Silver; P C Stark; D R Macdonald; Y Ino; D A Ramsay; D N Louis
Journal:  J Natl Cancer Inst       Date:  1998-10-07       Impact factor: 13.506

View more
  2 in total

1.  Genetic alterations of IDH1 and Vegf in brain tumors.

Authors:  Silvia Veganzones; Virginia de la Orden; Lucía Requejo; Beatriz Mediero; María Luisa González; Náyade Del Prado; Carmen Rodríguez García; Raquel Gutiérrez-González; Alvaro Pérez-Zamarrón; Armando Martínez; Marisa L Maestro; Horacio Mario Zimman; Anna González-Neira; Jesús Vaquero; Gregorio Rodríguez-Boto
Journal:  Brain Behav       Date:  2017-08-01       Impact factor: 2.708

2.  World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineages.

Authors:  Natsuki Hattori; Yuichi Hirose; Hikaru Sasaki; Shunsuke Nakae; Saeko Hayashi; Shigeo Ohba; Kazuhide Adachi; Takuro Hayashi; Yuya Nishiyama; Mitsuhiro Hasegawa; Masato Abe
Journal:  Cancer Sci       Date:  2016-06-22       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.